Literature DB >> 22801737

Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma.

Giuseppe Malleo1, Alfredo Tonsi, Giovanni Marchegiani, Andrea Casarotto, Salvatore Paiella, Giovanni Butturini, Roberto Salvia, Claudio Bassi.   

Abstract

PURPOSE: The aims of this paper were to evaluate the clinical features of patients with primary duodenal adenocarcinoma and to address the prognostic relevance of different surgical and pathological variables after potentially curative pancreaticoduodenectomy.
METHODS: Patients with primary duodenal adenocarcinoma observed from 2000 through 2009 were identified from a single-institution electronic database. Univariate and multivariate analyses were performed to identify factors associated with survival.
RESULTS: The study population consisted of 37 patients. Of these, 25 underwent pancreaticoduodenectomy, while the remaining 12 were not amenable to resection and underwent bypass operations or were given best supportive care. Overall survival after radical resection (R0) was significantly longer than after palliative surgery (180 versus 35 months, p = 0.013). On multivariate analysis, tumor grade (hazard ratio (HR) = 1.345, 95% CI = 1.28-1.91, p = 0.03) and the occurrence of postoperative or abdominal complications (HR = 1.781, 95% CI = 1.10-2.89, p = 0.037; HR = 1.878, 95% CI = 1.21-3.08, p = 0.029) were found to be significant prognostic factors for survival in patients undergoing potentially curative resection. In particular, median survival was 180 months in patients with an uneventful postoperative course and 52 months in those with abdominal complications. The 5-year overall survival rates were 100 and 60 %, respectively.
CONCLUSIONS: According to the present findings, the development of postoperative complications may be an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. This emphasizes the need for centralization to high-volume centers where an appropriate postoperative care can be delivered.

Entities:  

Mesh:

Year:  2012        PMID: 22801737     DOI: 10.1007/s00423-012-0978-9

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  37 in total

1.  Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer.

Authors:  C S McArdle; D C McMillan; D J Hole
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

2.  Improving survival in adenocarcinoma of the duodenum.

Authors:  D R Joesting; R W Beart; J A van Heerden; L H Weiland
Journal:  Am J Surg       Date:  1981-02       Impact factor: 2.565

3.  Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum.

Authors:  D Stell; D Mayer; D Mirza; J Buckels
Journal:  Dig Surg       Date:  2005-01-19       Impact factor: 2.588

4.  Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma.

Authors:  Peter J Kneuertz; Sameer H Patel; Carrie K Chu; Shishir K Maithel; Juan M Sarmiento; Keith A Delman; Charles A Staley; David A Kooby
Journal:  Ann Surg Oncol       Date:  2011-01-08       Impact factor: 5.344

5.  Prognostic factors for primary duodenal adenocarcinoma.

Authors:  Hyung Geun Lee; Dong Do You; Kwang Yeol Paik; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

6.  The diagnosis of primary tumours of the duodenum.

Authors:  T H BARCLAY; H P KENT
Journal:  Gut       Date:  1962-03       Impact factor: 23.059

7.  Poor prognosis in esophageal cancer patients with postoperative complications.

Authors:  T Hirai; Y Yamashita; H Mukaida; M Kuwahara; H Inoue; T Toge
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

8.  Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience.

Authors:  Fu-Chih Hung; Chung-Mou Kuo; Seng-Kee Chuah; Chung-Huang Kuo; Yaw-Sen Chen; Sheng-Nan Lu; Chi-Sin Chang Chien
Journal:  J Gastroenterol Hepatol       Date:  2007-05       Impact factor: 4.029

9.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

10.  Factors predictive of survival in ampullary carcinoma.

Authors:  J R Howe; D S Klimstra; R D Moccia; K C Conlon; M F Brennan
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

View more
  4 in total

Review 1.  Duodenal adenocarcinoma: Advances in diagnosis and surgical management.

Authors:  Jordan M Cloyd; Elizabeth George; Brendan C Visser
Journal:  World J Gastrointest Surg       Date:  2016-03-27

2.  Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes.

Authors:  Jana Tesarikova; Pavel Skalicky; Daniela Kurfurstova; Hana Svebisova; Ondrej Urban; Premysl Falt; Jana Zapletalova; Dusan Klos; Martin Lovecek
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-05-11       Impact factor: 1.648

3.  Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.

Authors:  Qing-Long Jiang; Xiang-Hui Huang; Ying-Tai Chen; Jian-Wei Zhang; Cheng-Feng Wang
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

4.  Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Laura L Meijer; Anna J Alberga; Jacob K de Bakker; Hans J van der Vliet; Tessa Y S Le Large; Nicole C T van Grieken; Ralph de Vries; Freek Daams; Barbara M Zonderhuis; Geert Kazemier
Journal:  Ann Surg Oncol       Date:  2018-06-26       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.